Dyspnea in palliative care: expanding the role of corticosteroids.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22385025.
- Also identified by DOI 10.1089/jpm.2011.0260 and PMC identifier 7001421.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dyspnea is one of the most common symptoms in advanced cancer patients at the end of their life. It is often multifactorial with diverse malignant, nonmalignant, and cancer treatment related etiologies. Oxygen, opiates, and anxiolytics are commonly administered. Here a complex case of progressive dyspnea and its treatments in a patient with advanced pancreatic cancer is described, and its multiple potential contributing causes are identified and clinical responses evaluated. Literature review is conducted on pulmonary drug toxicity and tumor lymphangitic spread, and the role of corticosteroids in relieving dyspnea in the palliative care setting.
Medical subject headings
- Adrenal Cortex Hormones
- Dyspnea
- Palliative Care
- Pancreatic Neoplasms